Skip to content
10-Q

Quarterly Report

BICYCLE THERAPEUTICS PLC BCYC

0001558370-25-006049

← back to feed
Filed
May 1, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Current Liabilities Q1 2025 · Mar 31, 2025 $57.62M
Current Liabilities Q1 2025 · Dec 31, 2024 $67.23M
Total Liabilities Q1 2025 · Mar 31, 2025 $143.56M
Total Liabilities Q1 2025 · Dec 31, 2024 $163.81M
Current Assets Q1 2025 · Mar 31, 2025 $856.09M
Current Assets Q1 2025 · Dec 31, 2024 $928.61M
Total Assets Q1 2025 · Mar 31, 2025 $883.89M
Total Assets Q1 2025 · Dec 31, 2024 $956.87M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $879.52M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $457M
Shares Diluted Q1 2025 · Mar 31, 2024 42.56M sh
Capex Q1 2025 · Mar 31, 2024 $12K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$70.87M
Stockholders Equity Q1 2025 · Mar 31, 2024 $356.05M
Stockholders Equity Q1 2025 · Dec 31, 2023 $370.93M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.62
Eps Basic Q1 2025 · Mar 31, 2024 −$0.62
Sga Expense Q1 2025 · Mar 31, 2024 $16.38M
Rd Expense Q1 2025 · Mar 31, 2024 $34.86M
Net Income Q1 2025 · Mar 31, 2024 −$26.56M
Operating Income Q1 2025 · Mar 31, 2024 −$31.72M
Revenue Q1 2025 · Mar 31, 2024 $19.53M